These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 57771)

  • 1. Investigations on d-galactosamine hepatitis after pretreatment with alpha-hexachlorocyclohexane.
    Schuchhardt C; Reutter W; Lesch R
    Beitr Pathol; 1976 Feb; 157(1):45-55. PubMed ID: 57771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 3. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 4. On the mechanism of action of galactosamine: different response to D-galactosamine of rat liver during development.
    Reutter W; Bauer C; Lesch R
    Naturwissenschaften; 1970 Dec; 57(12):674-5. PubMed ID: 5531365
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective role of prednisolone upon galactosamine-induced hepatitis in rats.
    Grases PJ; Reutter W; Lesch R
    G E N; 1972; 27(2):197-204. PubMed ID: 4201408
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting action of aspartate on the hepatic changes induced by D-galactosamine.
    Fodor O; Schvartz M; Suciu A; Barbarino F; Duca S; Lezeu R
    Arzneimittelforschung; 1976; 26(5):855-8. PubMed ID: 183787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 9. Orotate prevents galactosamine hepatitis.
    Keppler D; Rudigier J; Reutter W; Lesch R; Decker K
    Hoppe Seylers Z Physiol Chem; 1970 Jan; 351(1):102-4. PubMed ID: 5411959
    [No Abstract]   [Full Text] [Related]  

  • 10. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 11. Ongoing hepatocellular regeneration and resiliency toward galactosamine hepatotoxicity.
    Abdul-Hussain SK; Mehendale HM
    Arch Toxicol; 1992; 66(10):729-42. PubMed ID: 1290405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver injury induced by 2-deoxy-D-galactose.
    Keppler DO; Hübner G
    Exp Mol Pathol; 1973 Dec; 19(3):365-77. PubMed ID: 4763635
    [No Abstract]   [Full Text] [Related]  

  • 13. [Galactosamine-hepatitis].
    Reutter W; Lesch R; Keppler D; Decker K
    Naturwissenschaften; 1968 Oct; 55(10):497. PubMed ID: 5701857
    [No Abstract]   [Full Text] [Related]  

  • 14. Galactosamine- "hepatitis" in rats with different phagocytic activity of liver RES.
    Rasenack U; Grün M; Liehr H
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):29-35. PubMed ID: 1119301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
    Bauer C; Reutter W; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of the hepatotoxic effects of D-galactosamine by D-galactose.
    Mészáros K; Antoni F; Hrabák A; Szikla C; Garzó T; Tompa A; Lapis K
    FEBS Lett; 1973 Sep; 35(1):1-3. PubMed ID: 4751995
    [No Abstract]   [Full Text] [Related]  

  • 17. Colchicine prevents D-galactosamine-induced hepatitis.
    Mourelle M; Meza MA
    J Hepatol; 1989 Mar; 8(2):165-72. PubMed ID: 2565925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: The hepatotoxic effect of ethanol after pretreatment with carbon tetrachloride, allyl alcohol, or D-galactosamine.
    Strubelt O; Buettner F; Siegers CP
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R102. PubMed ID: 1170506
    [No Abstract]   [Full Text] [Related]  

  • 19. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advantages and limitations of the galactosamine model].
    Decker K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():245-9. PubMed ID: 1029184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.